Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin

Yi Liu; Uday K. Sukumar; Masamitsu Kanada; Anandi Krishnan; Tarik F. Massoud; Ramasamy Paulmurugan

doi:10.1002/adfm.202307769

Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin

Yi Liu, Uday K. Sukumar, Masamitsu Kanada, Anandi Krishnan, Tarik F. Massoud, Ramasamy Paulmurugan

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

Adv. Funct. Mater. 2021, 31, 2103600 Doi: 10.1002/adfm.202103600 The authors inadvertently and erroneously published two incorrect FLI mouse images for Day 15-control and Day 22-CPMV-antimiRs+Dox groups. The correct mouse images for these two panels are included in the revised Figure 5c shown below. (Figure presented.) Revised Figure 5c. These errors do not affect the conclusions of the report. The authors apologize for any inconvenience caused.

Original language	English (US)
Article number	2307769
Journal	Advanced Functional Materials
Volume	33
Issue number	37
DOIs	https://doi.org/10.1002/adfm.202307769
State	Published - Sep 12 2023
Externally published	Yes

All Science Journal Classification (ASJC) codes

Electronic, Optical and Magnetic Materials
General Chemistry
Biomaterials
General Materials Science
Condensed Matter Physics
Electrochemistry

Access to Document

10.1002/adfm.202307769

Cite this

@article{b0ead50268af4c7f8b6b4a4e0d5a975b,

title = "Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin",

abstract = "Adv. Funct. Mater. 2021, 31, 2103600 Doi: 10.1002/adfm.202103600 The authors inadvertently and erroneously published two incorrect FLI mouse images for Day 15-control and Day 22-CPMV-antimiRs+Dox groups. The correct mouse images for these two panels are included in the revised Figure 5c shown below. (Figure presented.) Revised Figure 5c. These errors do not affect the conclusions of the report. The authors apologize for any inconvenience caused.",

author = "Yi Liu and Sukumar, {Uday K.} and Masamitsu Kanada and Anandi Krishnan and Massoud, {Tarik F.} and Ramasamy Paulmurugan",

note = "Publisher Copyright: {\textcopyright} 2023 Wiley-VCH GmbH.",

year = "2023",

month = sep,

day = "12",

doi = "10.1002/adfm.202307769",

language = "English (US)",

volume = "33",

journal = "Advanced Functional Materials",

issn = "1616-301X",

publisher = "Wiley-VCH Verlag",

number = "37",

}

TY - JOUR

T1 - Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin

AU - Liu, Yi

AU - Sukumar, Uday K.

AU - Kanada, Masamitsu

AU - Krishnan, Anandi

AU - Massoud, Tarik F.

AU - Paulmurugan, Ramasamy

PY - 2023/9/12

Y1 - 2023/9/12

N2 - Adv. Funct. Mater. 2021, 31, 2103600 Doi: 10.1002/adfm.202103600 The authors inadvertently and erroneously published two incorrect FLI mouse images for Day 15-control and Day 22-CPMV-antimiRs+Dox groups. The correct mouse images for these two panels are included in the revised Figure 5c shown below. (Figure presented.) Revised Figure 5c. These errors do not affect the conclusions of the report. The authors apologize for any inconvenience caused.

AB - Adv. Funct. Mater. 2021, 31, 2103600 Doi: 10.1002/adfm.202103600 The authors inadvertently and erroneously published two incorrect FLI mouse images for Day 15-control and Day 22-CPMV-antimiRs+Dox groups. The correct mouse images for these two panels are included in the revised Figure 5c shown below. (Figure presented.) Revised Figure 5c. These errors do not affect the conclusions of the report. The authors apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85171190731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85171190731&partnerID=8YFLogxK

U2 - 10.1002/adfm.202307769

DO - 10.1002/adfm.202307769

M3 - Comment/debate

AN - SCOPUS:85171190731

SN - 1616-301X

VL - 33

JO - Advanced Functional Materials

JF - Advanced Functional Materials

IS - 37

M1 - 2307769

ER -

Camouflaged Hybrid Cancer Cell-Platelet Fusion Membrane Nanovesicles Deliver Therapeutic MicroRNAs to Presensitize Triple-Negative Breast Cancer to Doxorubicin

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this